http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2645931-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16c2dd8fba07b48ce453d9766f417bbe |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-142 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-14 |
| filingDate | 2017-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ba581d4a3380c10e321bcfa817c2707 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7051a97392bb01f1921a81f8f88f182a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b979190899b68ad73f1b0591f4f9d122 |
| publicationDate | 2018-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2645931-C1 |
| titleOfInvention | Keratectasias treatment method |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to medicine, specifically to ophthalmology. For the treatment of keratectasias the Bowman membrane donor transplant is subjected to cross-linking and implanted into the intrastromal pocket of the recipient. Intrastromal pocket is formed mainly at a depth of 50 % of the Descemet's membrane. Crosslinking is carried out under UV irradiation with a power density of 3 mW/cm 2 for 15 minutes. Before UV irradiation, the Bowman membrane transplant is placed in a 0.1 % riboflavin solution for 15 minutes. Method provides the possibility of surgical treatment at a thickness of the cornea less than 400 mcm, K value over 58 diopter with an increase in the thickness of the cornea and a change in the curvature of the cornea with the possibility of subsequently performing a standard cross-linking of the cornea. n EFFECT: proposed is a keratectasias treatment method. n 4 cl, 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2735377-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2765018-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2703361-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2698445-C1 |
| priorityDate | 2017-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.